Mutant calreticulin causes essential thrombocythemia

被引:0
|
作者
Shimoda, Kazuya [1 ]
Shide, Kotaro [1 ]
Kameda, Takuro [1 ]
机构
[1] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan
关键词
CALR; JAK2; MYELOPROLIFERATIVE NEOPLASMS; THROMBOPOIETIN RECEPTOR; ACTIVATION;
D O I
10.18632/oncotarget.21292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:88251 / 88252
页数:2
相关论文
共 50 条
  • [41] Essential thrombocythemia in children and adolescents analysis of 31 cases
    Ershov, N. M.
    Gaskova, M., V
    Pshonkin, A., V
    Olshanskaya, Yu, V
    Konyukhova T, V
    Abramov, D. S.
    Levin, P. A.
    Poletaev, A., V
    Seregina, E. A.
    Plyasunova, S. A.
    Maschan, A. A.
    Smetanina, N. S.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (04): : 480 - 498
  • [42] Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and Management
    Puglianini, Omar Castaneda
    Peker, Deniz
    Zhang, Linsheng
    Papadantonakis, Nikolaos
    LABORATORY MEDICINE, 2023, 54 (01) : 13 - 22
  • [43] Targeted deep sequencing in polycythemia vera and essential thrombocythemia
    Tefferi, Ayalew
    Lasho, Terra L.
    Guglielmelli, Paola
    Finke, Christy M.
    Rotunno, Giada
    Elala, Yoseph
    Pacilli, Annalisa
    Hanson, Curtis A.
    Pancrazzi, Alessandro
    Ketterling, Rhett P.
    Mannarelli, Carmela
    Barraco, Daniela
    Fanelli, Tiziana
    Pardanani, Animesh
    Gangat, Naseema
    Vannucchi, Alessandro M.
    BLOOD ADVANCES, 2016, 1 (01) : 21 - 30
  • [44] Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
    Qiao, Chun
    Sun, Chao
    Ouyang, Yuan
    Wang, Ju-Juan
    Qian, Si-Xuan
    Li, Jian-Yong
    Zhang, Su-Jiang
    HAEMATOLOGICA, 2014, 99 (10) : E182 - E184
  • [45] Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities
    Fosselteder, Johannes
    Pabst, Gabriel
    Sconocchia, Tommaso
    Schlacher, Angelika
    Auinger, Lisa
    Kashofer, Karl
    Beham-Schmid, Christine
    Trajanoski, Slave
    Waskow, Claudia
    Schoell, Wolfgang
    Sill, Heinz
    Zebisch, Armin
    Woelfler, Albert
    Thomas, Daniel
    Reinisch, Andreas
    LEUKEMIA, 2023, 37 (04) : 843 - 853
  • [46] Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era
    Falchi, L.
    Kantarjian, H. M.
    Verstovsek, S.
    LEUKEMIA, 2017, 31 (09) : 1845 - 1854
  • [47] ASXL1 mutations in Chinese patients with essential thrombocythemia
    Nie, Yan-Bo
    Sun, Meng
    He, Colin K.
    Ju, Man-Kai
    Zhou, Fu-Ling
    Wu, San-Yun
    Zhou, Yi
    Liu, Li
    Shen, Hui
    Huang, Ting-Ting
    Liu, Pan
    Xu, Ying
    Shao, Liang
    Zuo, Xue-Lan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (05) : 4149 - 4156
  • [48] A rare CALR variant mutation and a review of CALR in essential thrombocythemia
    Diep, Robert
    Metjian, Ara
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (03) : 457 - 462
  • [49] Essential Thrombocythemia: One-Center Data in a Changing Disease
    Pirciulescu, Nicoleta
    Gaman, Mihnea-Alexandru
    Mihailescu, Marina
    Constantin, Cristina
    Dragomir, Mihaela
    Dobrea, Camelia
    Costache, Simona
    Ursuleac, Iulia
    Coriu, Daniel
    Crisan, Ana Manuela
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [50] Essential Thrombocythemia: The Dermatologic Point of View
    Cozzani, Emanuele
    Iurlo, Alessandra
    Merlo, Giulia
    Cattaneo, Daniele
    Burlando, Martina
    Pierri, Ivana
    Gugliotta, Luigi
    Parodi, Aurora
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (12): : 739 - 747